What’s new

• Sanofi Consumer Healthcare India appointed Price Waterhouse & Co (PwC) as its statutory auditor.
• The appointment fills a vacancy left by the resignation of Kalyaniwalla & Mistry LLP on 30 April 2026.
• PwC will serve a full five-year term through 2031, subject to shareholder approval.

Why it matters

Replacing a departed auditor with a Big Four firm is a governance upgrade, not just a replacement. For a mid-cap company, locking in PwC for five years signals intent to stabilise audit oversight after the abrupt resignation. The market had likely priced in a change, but the choice of a global network over a local firm is a concrete step toward higher reporting standards.

What we’re watching

• Shareholder vote on PwC's appointment at the next AGM.
• Any disclosure on the reasons behind Kalyaniwalla & Mistry's resignation.
• Whether PwC's tenure brings changes to financial-disclosure practices.

The full read

Sanofi Consumer Healthcare India has hired PwC to replace Kalyaniwalla & Mistry LLP, whose resignation on 30 April 2026 left the company without a statutory auditor. The appointment is a five-year term through 2031, pending shareholder approval at the next annual general meeting. For a mid-cap company, locking in a Big Four firm for the long haul is more than a procedural fix. It upgrades the audit bench after an unplanned exit. It does so with a global network rather than a local replacement. The prior resignation was already in the market; what's new is the calibre of the successor. The tenure length also removes the near-term uncertainty of a short-term placeholder, giving PwC enough runway to embed itself in the company's reporting cycle.

Primary source: BSE · NSE